SUBSTITUTION OF GLUTAMINE FOR ARGININE-1131 - A NEWLY IDENTIFIED MUTATION IN THE CATALYTIC LOOP OF THE TYROSINE KINASE DOMAIN OF THE HUMAN INSULIN-RECEPTOR
M. Kishimoto et al., SUBSTITUTION OF GLUTAMINE FOR ARGININE-1131 - A NEWLY IDENTIFIED MUTATION IN THE CATALYTIC LOOP OF THE TYROSINE KINASE DOMAIN OF THE HUMAN INSULIN-RECEPTOR, The Journal of biological chemistry, 269(15), 1994, pp. 11349-11355
We studied a patient with severe insulin resistance and a remarkable d
ecrease in the in vivo autophosphorylation of the insulin receptor. Us
ing a polymerase chain reaction-single strand conformation polymorphis
m method and direct sequencing, we identified a heterozygous mutation
substituting Gln for Arg1131 in the putative ''catalytic loop'' of the
tyrosine kinase domain of the insulin receptor gene. The Gln113 mutan
t receptor was expressed by transfection in Chinese hamster ovary cell
s and compared with cells expressing the wild-type insulin receptor. B
oth mutant and wild-type receptors were expressed on the cell surface
and displayed similar insulin-binding affinity. The Gln1131 mutation i
mpaired the activity of the receptor tyrosine kinase and inhibited the
ability of insulin to phosphorylate the endogenous substrate insulin
receptor substrate-I. In addition, the Gln1131 mutant receptor exhibit
ed diminished tyrosine-phosphorylated phosphatidylinositol 3-kinase an
d myelin basic protein kinase activities compared with the wild-type c
ells. It also demonstrated a defective mediation of the insulin signal
stimulating 2-deoxy-D-glucose transport and thymidine incorporation,
resistance to endocytosis, and insulin-induced down-regulation. Unlike
a previously described mutation in the putative catalytic loop of the
receptor that substituted Glu for Ala1135, the Gln1131 mutation retai
ned proteolytic cleavage of the proreceptor into separate subunits. Ou
r results demonstrate that a naturally occurring mutation (R1131Q) in
the putative catalytic loop of the insulin receptor results in severe
impairment of the tyrosine kinase function in our patient. In addition
, our results indicate that Arg1131 is important for receptor-mediated
insulin action in vivo and suggest that the amino acids constituting
the catalytic loop of protein kinases may possess different modes in o
rder to retain kinase function.